`Filed: June 10, 2016
`
`
`
`
`Filed on behalf of: AstraZeneca AB
`By:
`
`
`
`
`
`Charles E. Lipsey
`Finnegan, Henderson, Farabow,
` Garrett & Dunner, L.L.P.
`11955 Freedom Drive
`Reston, VA 20190
`Tel: 571-203-2700
`Fax: 202-208-4400
`Email: Charles.lipsey@finnegan.com
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`___________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`___________________________________
`
`AUROBINDO PHARMA U.S.A., INC. and A
`UROBINDO PHARMA LTD,
`Petitioners,
`
`v.
`
`ASTRAZENECA AB,
`Patent Owner
`
`___________________________________
`
`Case IPR2016-01117
`Patent No. RE44,186
`
`___________________________________
`
`PATENT OWNER’S MANDATORY NOTICES
`UNDER 37 C.F.R. §42.8(a)(2)
`
`
`
`
`
`In accordance with 37 C.F.R. §42.8(a)(2), Patent Owner AstraZeneca AB
`
`submits the following mandatory notices regarding the Petition for Inter Partes
`
`Review of U.S. Patent No. RE44,186 (“the ’186 patent”). This notice is being
`
`timely filed within 21 days (June 23, 2016) of service of the petition (June 2,
`
`2016).
`
`Real parties-in-interest (§42.8(b)(1)): AstraZeneca AB is the Patent Owner and
`
`the real party-in-interest.
`
`Related Matters (§42.8(b)(2)): Judicial – AstraZeneca AB v. Mylan
`
`Pharmaceuticals Inc., 14-cv-00696 (D. Del. 2014); AstraZeneca AB v. Mylan
`
`Pharmaceuticals Inc., 14-cv-00094 (D.W. Va. 2014); AstraZeneca AB v.
`
`Aurobindo Pharma Ltd. et al., 14-cv-014696 and 14-cv-00664 (D. Del 2014);
`
`AstraZeneca AB v. Watson Laboratories, Inc., 14-cv-01051 (D. Del. 2014);
`
`AstraZeneca AB v. Actavis Laboratories FL, Inc., 14-cv-01356 (D. Del. 2014);
`
`AstraZeneca AB v. Sun Pharma Global FZE et al., 14-cv-00694 (D. Del. 2014);
`
`AstraZeneca AB v. Amneal Pharmaceuticals LLC., 14-cv-00697 (D. Del. 2014);
`
`and AstraZeneca AB v. Wockhardt Bio AG et al., 14-cv-00696 (D. Del. 2014).
`
`Administrative – Mylan Pharmaceuticals Inc. v. AstraZeneca AB (IPR2015-
`
`01340). Administrative (pending institution and/or joinder) – Wockhardt BIO
`
`AG v. AstraZeneca AB (IPR2016-01029); Sun Pharmaceutical Industries, Ltd., Sun
`
`
`
`1
`
`
`
`
`
`
`Case IPR2016-01117 for
`U.S. Patent No. RE44,186
`
`Pharma Global FZE, and Amneal Pharmaceuticals LLC v. AstraZeneca AB
`
`(IPR2016-01104); and Teva Pharmaceuticals U.S.A., Inc. v. AstraZeneca AB
`
`(IPR2016-01122).
`
`Lead and Back-Up Counsel (§42.8(b)(4))
`
`Lead Counsel for AstraZeneca AB is:
`
`Charles E. Lipsey, Reg. No. 28,165
`charles.lipsey@finnegan.com
`Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
`11955 Freedom Drive
`Reston, VA 20190
`Tel: 571-203-2700
`Fax: 202-208-4400
`
`
`
`Back-Up Counsel for AstraZeneca AB is:
`
`Eric E. Grondahl, Reg. No. 46,741
`egrondahl@mccarter.com
`McCarter & English LLP
`CityPlace I
`185 Asylum St.
`Hartford, CT 06103
`Tel: 860-275-6704
`Fax: 860-724-3397
`
`John D. Livingstone, Reg. No. 59,613
`john.livingstone@finnegan.com
`Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
`271 17th Street, NW, Suite 1400
`Atlanta, GA 30363
`Tel: 404-653-6400
`Fax: 404-653-6444
`
`2
`
`
`
`
`
`
`
`
`
`Case IPR2016-01117 for
`U.S. Patent No. RE44,186
`
`Anthony A. Hartmann, Reg. No. 43,662
`anthony.hartmann@finnegan.com
`Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Tel: 202-408-4275
`Fax: 202-408-4000
`
`M. David Weingarten, Reg. No. 54,533
`david.weingarten@finnegan.com
`Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
`271 17th Street, NW, Suite 1400
`Atlanta, GA 30363
`Tel: 404-653-6400
`Fax: 404-653-6444
`
`
`
`
`
`
`
`
`
`
`
`
`Service Information (§42.8(b)(4)) Please address all correspondence to the lead
`
`and backup counsel as shown above. Patent Owner consents to electronic service
`
`by e-mail at the e-mail addresses provided above.
`
`
`
`Dated: June 10, 2016
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`
` By:
`
`/Charles E. Lipsey/
`Charles E. Lipsey, Reg. No. 28,165
`Charles.Lipsey@finnegan.com
`Finnegan, Henderson, Farabow,
` Garrett & Dunner, L.L.P.
`11955 Freedom Drive
`Reston, VA 20190
`Tel: 571-203-2700
`Fax: 202-208-4400
`
`Counsel for Patent Owner
`
`
`
`3
`
`
`
`
`
`
`Case IPR2016-01117 for
`U.S. Patent No. RE44,186
`
`CERTIFICATE OF SERVICE
`
`Pursuant to §§42.6(e)(1), I certify that a true and correct copy of the
`
`foregoing Patent Owner’s Mandatory Notices Under 37 C.F.R. §42.8 was served
`by electronic mail on this 10th day of June, 2016 on Petitioner’s counsel of record
`as follows:
`
`Sailesh K. Patel
`SCHIFF HARDIN LLP
`233 South Wacker Drive, Suite 6600
`Chicago, IL 60606
`SPatel@schiffhardin.com
`
`
`George C. Yu
`SCHIFF HARDIN LLP
`One Market Plaza
`Spear Street Tower, #3200
`San Francisco, CA 94105
`GYu@schiffhardin.com
`
`
`
`Dated: June 10, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`
`
`
`
`/Sheila Y. West/
`
`Sheila Y. West
`Litigation Assistant
`Finnegan, Henderson, Farabow,
`Garrett & Dunner, L.L.P.